Results of shareholder votes disclosed under 8-K Item 5.07.
Teads Holding Co. shareholders approved Non-Binding Advisory Vote on the Frequency of Future Advisory Votes on the Compensation of our Named Executive Officers at the 2026-05-14 meeting.
“To cast an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 72,126,473 28,848 262,992 14,843 12,464,010”
Teads Holding Co. shareholders approved Non-Binding Advisory Vote on the Compensation of our Named Executive Officers at the 2026-05-14 meeting.
“To approve, on an advisory basis, the compensation of our named executive officers, described in the proxy statement: For Against Abstain Broker Non-Votes 64,163,830 8,225,154 44,172 12,464,010”
Teads Holding Co. shareholders approved Election of Dexter Goei as a Class II director at the 2026-05-14 meeting.
“To elect Dexter Goei as a Class II director of the Company to serve for a three-year term until the 2029 Annual Meeting of Stockholders and until the director’s successor has been duly elected and qualified: For Withhold Broker Non-Votes 66,203,787 6,229,369 12,464,010”
Core Scientific, Inc./tx shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-12 meeting.
“Proposal 3: To ratify the appointment of KPMG LLP”
Core Scientific, Inc./tx shareholders approved Advisory approval of named executive officer compensation as disclosed in the 2026 Proxy Statement at the 2026-05-12 meeting.
“Proposal 2: To approve on a non-binding, advisory basis, the compensation of our named executive officers”
Core Scientific, Inc./tx shareholders approved Election of five nominees to the Board of Directors at the 2026-05-12 meeting.
“Nominee For Withheld Broker Non-Votes Adam Sullivan 217,650,785 2,469,826 44,778,216 Jeff Booth 168,580,185 51,540,426 44,778,216 Elizabeth Crain 215,074,279 5,046,332 44,778,216 Yadin Rozov 213,054,408 7,066,203 44,778,216 Eric Weiss 168,947,230 51,173,381 44,778,216”
ENTERPRISE FINANCIAL SERVICES CORP shareholders approved Advisory (Non-Binding) Vote to Approve Executive Compensation at the 2026-05-13 meeting.
“The proposal to approve, on an advisory basis, the compensation of the Company's named executive officers, as described in the Proxy Statement, was approved by the following votes:”
ENTERPRISE FINANCIAL SERVICES CORP shareholders approved Ratification of the Appointment of the Independent Registered Public Accounting Firm at the 2026-05-13 meeting.
“The appointment of Deloitte & Touche LLP to serve as the Company's independent registered public accounting firm for fiscal year 2026 was ratified as follows:”
ENTERPRISE FINANCIAL SERVICES CORP shareholders approved Election of the twelve nominees named in the Company's proxy statement to serve a one-year term at the 2026-05-13 meeting.
“The twelve nominees named in the Company’s proxy statement for the 2026 Annual Meeting (the “Proxy Statement”) were elected to serve a one-year term expiring in 2027 or until their successors are duly elected and qualified, based upon the following votes:”
KRATOS DEFENSE & SECURITY SOLUTIONS, INC. shareholders approved Advisory vote on compensation of named executive officers at the 2026-05-12 meeting.
“The stockholders considered a proposal to approve, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers, as presented in the Company’s Proxy Statement.”
KRATOS DEFENSE & SECURITY SOLUTIONS, INC. shareholders approved Approve amendment and restatement of 2023 Equity Incentive Plan to increase shares by 6,900,000 at the 2026-05-12 meeting.
“The stockholders considered a proposal to approve an amendment and restatement of the 2023 Equity Incentive Plan to increase the number of shares of Common Stock issuable under such plan by 6,900,000 shares, as presented in the Company’s Proxy Statement.”
KRATOS DEFENSE & SECURITY SOLUTIONS, INC. shareholders approved Approve amendment to Certificate of Incorporation to provide for officer exculpation at the 2026-05-12 meeting.
“The stockholders considered a proposal to approve an amendment to the Company’s Certificate of Incorporation to provide for officer exculpation, as presented in the Company’s Proxy Statement.”
KRATOS DEFENSE & SECURITY SOLUTIONS, INC. shareholders approved Approve amendment to Certificate of Incorporation to increase authorized shares of Common Stock from 195,000,000 to 245,000,000 at the 2026-05-12 meeting.
“The stockholders considered a proposal to approve an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of Common Stock from 195,000,000 to 245,000,000, as presented in the Company’s Proxy Statement.”
KRATOS DEFENSE & SECURITY SOLUTIONS, INC. shareholders approved Ratify selection of Deloitte & Touche LLP as independent registered public accounting firm at the 2026-05-12 meeting.
“The stockholders considered a proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 27, 2026.”
KRATOS DEFENSE & SECURITY SOLUTIONS, INC. shareholders approved Election of Directors at the 2026-05-12 meeting.
“The stockholders considered a proposal to elect each of the individuals named below as directors to serve until the next annual meeting or until their successors are duly elected and qualified.”
CaliberCos Inc. shareholders approved Ratification of the appointment of Urish Popeck & Co., LLC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 at the 2026-05-14 meeting.
“Proposal 2 : Ratification of the appointment of Urish Popeck & Co., LLC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. For Against Abstain Broker Non-Votes 5,864,763 66,964 59,024 —”
CaliberCos Inc. shareholders approved Election of five directors to serve for a term ending as of the Company's annual meeting in 2027 at the 2026-05-14 meeting.
“Proposal 1 : Election of five directors to serve for a term ending as of the Company’s annual meeting in 2027. Director Nominee For Against Abstain Broker Non-Votes John C. Loeffler, II 4,344,746 - 28,874 1,617,131 Jennifer Schrader 4,351,161 - 22,459 1,617,131 William J. Gerber 4,336,718 - 36,901 1,617,132 Lawrence X. Taylor III 4,343,396 - 30,224 1,617,131 Jerome Alan Reid, Jr. 4,344,219 - 29,401 1,617,131”
Nurix Therapeutics, Inc. shareholders approved Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers at the 2026-05-15 meeting.
“Votes For Votes Against Abstentions Broker Non-Votes 72,458,920 6,895,394 573,204 3,819,495”
Nurix Therapeutics, Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending November 30, 2026 at the 2026-05-15 meeting.
“Votes For Votes Against Abstentions Broker Non-Votes 83,555,977 166,391 24,645 —”
Nurix Therapeutics, Inc. shareholders approved Election of three Class III directors at the 2026-05-15 meeting.
“Nominee Votes For Votes Withheld Broker Non-Votes Arthur T. Sands, M.D., Ph.D. 63,592,948 16,334,570 3,819,495 Roger Dansey, M.D. 79,607,489 320,029 3,819,495 Paul M. Silva 59,298,612 20,628,906 3,819,495”
ALERUS FINANCIAL CORP shareholders approved Ratification of the appointment of RSM US LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 at the 2026-05-14 meeting.
“Proposal 3 : The ratification of the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026: Votes For Votes Against Abstentions Broker Non-Votes 20,405,133 244,190 3,648 1,386”
ALERUS FINANCIAL CORP shareholders approved Approval, on a non-binding advisory basis, of the 2025 compensation paid to the Company's named executive officers at the 2026-05-14 meeting.
“Proposal 2: For the approval, on a non-binding advisory basis, of the 2025 compensation paid to the Company’s named executive officers: Votes For Votes Against Abstentions Broker Non-Votes 13,525,678 462,923 187,447 6,478,309”
ALERUS FINANCIAL CORP shareholders approved Election of nine director nominees to serve on the Board of Directors until the 2027 Annual Meeting at the 2026-05-14 meeting.
“Proposal 1 : The election of nine (9) director nominees to serve on the Board of Directors of the Company until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Director Nominee Votes For Votes Withheld Broker Non-Votes Daniel E. Coughlin 12,742,063 1,433,986 6,478,308 Randy L. Newman 10,813,971 3,362,078 6,478,308 Galen G. Vetter 12,876,320 1,299,729 6,478,308 Katie A. Lorenson 12,952,431 1,223,618 6,478,308 Janet O. Estep 12,299,613 1,876,436 6,478,308 Mary E. Zimmer 12,936,989 1,239,060 6,478,308 Nikki L. Sorum 13,065,204 1,110,845 6,478,308 John Uribe 12,897,761 1,278,288 6,478,308 Jeffrey W. Bolton 13,109,347 1,066,702 6,478,308”
FIRST SOLAR, INC. shareholders rejected Stockholder proposal to improve shareholder ability to call for a special shareholder meeting at the 2026-05-13 meeting.
“Stockholders did not approve a stockholder proposal to improve shareholder ability to call for a special shareholder meeting.”
FIRST SOLAR, INC. shareholders approved Advisory resolution on the compensation of named executive officers at the 2026-05-13 meeting.
“Stockholders approved an advisory resolution on the compensation of our named executive officers.”
FIRST SOLAR, INC. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026 at the 2026-05-13 meeting.
“Stockholders ratified the appointment of PricewaterhouseCoopers LLP as First Solar, Inc.'s independent registered public accounting firm for the year ending December 31, 2026.”
FIRST SOLAR, INC. shareholders approved Election of ten nominees as members of the board of directors at the 2026-05-13 meeting.
“Stockholders elected each of the following ten nominees as members of the board of directors to hold office until the next annual meeting of stockholders or until their respective successors have been elected and qualified.”
FLOTEK INDUSTRIES INC/CN/ shareholders approved Ratification of appointment of KPMG LLP as independent auditor for 2026 at the 2026-05-15 meeting.
“Item 3: Ratification of appointment of KPMG LLP as independent auditor for 2026. For Against Abstain Broker Non-Votes 27,040,174 130,313 5,194 N/A”
FLOTEK INDUSTRIES INC/CN/ shareholders approved Advisory vote to approve named executive officer compensation at the 2026-05-15 meeting.
“Item 2: Advisory vote to approve named executive officer compensation. For Against Abstain Broker Non-Votes 23,681,102 275,263 17,916 3,201,400”
FLOTEK INDUSTRIES INC/CN/ shareholders approved Election of Directors at the 2026-05-15 meeting.
“Item 1: Election of Directors. Nominee For Against Abstain Broker Non-Votes Harsha V. Agadi 23,790,803 174,144 9,334 3,201,400 Ryan G. Ezell 23,892,958 72,800 8,523 3,201,400 Evan R. Farber 23,459,901 505,376 9,004 3,201,400 Michael Fucci 23,592,112 373,163 9,006 3,201,400 Katie Hill 23,886,390 82,858 5,033 3,201,400 Kevin M. McDonald 23,888,701 77,226 8,354 3,201,400 Matt D. Wilks 23,852,353 84,169 37,759 3,201,400”
Indivior Pharmaceuticals, Inc. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-05-13 meeting.
“4. To ratify the appointment of PricewaterhouseCoopers LLP US (PwC) as our independent registered public accounting firm for the fiscal year ending December 31, 2026: Votes For Votes Against Votes Abstained Broker Non-Votes 99,146,241 1,237,984 23,497 0”
Indivior Pharmaceuticals, Inc. shareholders approved Advisory vote on preferred frequency of say-on-pay votes at the 2026-05-13 meeting.
“3. To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers (Say-on-Frequency): Votes For 1 Year Votes For 2 Years Votes For 3 Years Votes Abstained Broker Non-Votes 91,848,954 21,701 1,032,941 34,100 7,470,026”
Indivior Pharmaceuticals, Inc. shareholders approved Advisory vote to approve compensation of named executive officers at the 2026-05-13 meeting.
“2. To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement (Say-on-Pay): Votes For Votes Against Votes Abstained Broker Non-Votes 90,364,566 1,324,996 1,248,134 7,470,026”
Indivior Pharmaceuticals, Inc. shareholders approved Election of eight director nominees each to serve for a one-year term until 2027 Annual Meeting at the 2026-05-13 meeting.
“1. To elect eight director nominees, each to serve for a one-year term extending until our 2027 Annual Meeting of Shareholders and until their successors are duly elected and qualified: Nominee Votes For Votes Against Votes Abstained Broker Non-Votes Dr. David Wheadon 91,378,828 1,534,064 24,804 7,470,026 Joe Ciaffoni 92,834,811 76,839 26,046 7,470,026 Dr. Keith Humphreys 92,839,955 72,084 25,657 7,470,026 Tony Kingsley 92,839,469 72,503 25,724 7,470,026 Daniel Ninivaggi 87,545,032 5,366,849 25,815 7,470,026 Barbara Ryan 91,562,195 1,302,383 73,118 7,470,026 Mark Stejbach 92,838,962 72,847 25,887 7,470,026 Juliet Thompson 92,136,342 728,040 73,314 7,470,026”
Enact Holdings, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Corporation’s independent registered public accounting firm for the 2026 fiscal year at the 2026-05-13 meeting.
“Proposal 3: Ratification of the appointment of KPMG LLP as the Corporation’s independent registered public accounting firm for the 2026 fiscal year. Votes “For” Votes “Against” Abstentions Broker Non-Votes 138,540,938 765,884 1,206 -”
Enact Holdings, Inc. shareholders approved Advisory vote to approve Named Executive Officer compensation at the 2026-05-13 meeting.
“Proposal 2: Advisory vote to approve Named Executive Officer compensation. Votes “For” Votes “Against” Abstentions Broker Non-Votes 137,729,223 538,585 7,447 1,032,773”
Enact Holdings, Inc. shareholders approved Election of directors to serve until the Corporation’s 2027 Annual Meeting of Stockholders at the 2026-05-13 meeting.
“On May 13, 2026, the Corporation held its Annual Meeting of Stockholders (the “Annual Meeting”). The final voting results for each of the proposals submitted to a vote of the Corporation’s stockholders at the Annual Meeting are as follows: Proposal 1: Election of directors to serve until the Corporation’s 2027 Annual Meeting of Stockholders.”
Helio Corp /FL/ shareholders approved Amendment to the Articles of Incorporation to effect a reverse stock split of the Company's issued and outstanding Common Stock at a ratio within the range of 1.25-for-1 to 5-for-1, with the exact ratio and timing to be determined by the Board of Directors at the 2026-05-11 meeting.
“By the Written Consent, the majority shareholders approved and authorized an amendment to the Company’s Articles of Incorporation to effect a reverse stock split of the Company’s issued and outstanding Common Stock (the “ Reverse Stock Split ”) at a ratio within the range of 1.25-for-1 to 5-for-1, with the exact ratio and timing to be determined by the Board of Directors (or a duly authorized committee thereof) in its sole discretion at any time within 12 months following the date of the Written Consent.”
Cheniere Energy, Inc. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for 2026 at the 2026-05-14 meeting.
“The shareholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for 2026.”
Cheniere Energy, Inc. shareholders approved Advisory and non-binding vote to approve the compensation of the Company's named executive officers for 2025 at the 2026-05-14 meeting.
“In an advisory and non-binding vote, the shareholders approved the compensation paid for 2025 to the Company's named executive officers, as disclosed in the 2026 Proxy Statement.”
Cheniere Energy, Inc. shareholders approved Election of Directors at the 2026-05-14 meeting.
“Each of the director nominees was elected as a director to serve for a one-year term until the 2027 annual meeting of shareholders or until his or her successor is duly elected and qualified.”
INSMED Inc shareholders approved Ratification of the Appointment of an Independent Registered Public Accounting Firm at the 2026-05-13 meeting.
“By the following vote, shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026: For Against Abstentions 190,386,612 6,997,613 45,308”
INSMED Inc shareholders approved Advisory Vote on the 2025 Compensation of Named Executive Officers at the 2026-05-13 meeting.
“By the following vote, shareholders approved, on an advisory, non-binding basis, the 2025 compensation of our named executive officers, as disclosed in the Proxy Statement: For Against Abstentions Broker Non-Votes 162,133,728 23,657,325 74,398 11,564,082”
INSMED Inc shareholders approved Election of Two Class II Directors at the 2026-05-13 meeting.
“By the following votes, shareholders elected Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D., to serve as Class II directors until the Company’s 2029 Annual Meeting of Shareholders: For Withheld Broker Non-Votes Elizabeth McKee Anderson 153,734,471 32,130,980 11,564,082 Clarissa Desjardins, Ph.D. 164,437,828 21,427,623 11,564,082”
Frontier Group Holdings, Inc. shareholders approved Advisory Approval of the Compensation of the Company’s Named Executive Officers at the 2026-05-14 meeting.
“The Company’s stockholders approved, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers for the fiscal year ended December 31, 2025, as disclosed in the Company’s proxy statement for the Annual Meeting pursuant to the compensation disclosure rules of the Securities and Exchange Commission.”
Frontier Group Holdings, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-14 meeting.
“The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Frontier Group Holdings, Inc. shareholders approved Election of Directors at the 2026-05-14 meeting.
“The Company’s stockholders elected Andrew S. Broderick, Bernard L. Han, Anthony D. Salcido and Alejandro D. Wolff as members of the Company’s board of directors as Class II directors for a three-year term.”
CEMTREX INC shareholders approved Ratification of Grassi Co. Certified Public Accountants as independent registered public accounting firm at the 2026-05-15 meeting.
“Proposal 2 - Ratification of the Appointment of the Company’s Independent registered public accounting firm”
CEMTREX INC shareholders approved Election of four nominees to the Board of Directors at the 2026-05-15 meeting.
“Number of Votes Nominee For Abstain Broker Non-Votes Saagar Govil 102,741,275 495,703 4,399,719 Brian Kwon 102,988,319 248,658 4,399,720 Manpreet Singh 102,954,394 282,583 4,399,720 Mitodi Filipov 102,987,501 249,476 4,399,720”
IDEXX LABORATORIES INC /DE shareholders rejected Shareholder proposal to give shareholders the ability to call for a special shareholder meeting at the 2026-05-12 meeting.
“Proposal Six: Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting. For 28,179,566 Against 40,019,951 Abstain 227,294 Broker Non-Votes 4,524,699”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.